China NMPA Product Recall - Rheumatoid factor assay kit (latex immunoturbidimetric assay)

Abbott Trading (Shanghai) Co., Ltd. initiated a voluntary Class III recall for specific batches of its Rheumatoid Factor Assay Kit (Latex Immunoturbidimetric Assay). This action, reported on April 22, 2019, falls under the regulatory oversight of the National Medical Products Administration (NMPA) and the Shanghai Food and Drug Administration. The company identified that the affected assay kits might experience high-frequency calibration failures, which could compromise the accuracy and reliability of diagnostic results, posing potential risks in patient care. This proactive measure stems from the company's commitment to product quality and patient safety, aligning with the stringent regulatory framework in China. While specific inspection dates are not detailed, the recall itself is a result of identified performance issues. Detailed information regarding affected models, specifications, and batch numbers is provided in an accompanying "Medical Device Recall Event Report Form," ensuring transparency and a structured approach to this product correction.